Andrew Huberman advises testing sleep or cognitive compounds individually for seven days before combining them. This scientific method isolates which variable actually improves outcomes and prevents paying for redundant compounds. If an ingredient causes adverse side effects, people can immediately eliminate it from their regimen.
Andrew Huberman warns that supplemental melatonin induces initial drowsiness but fails to keep people asleep throughout the night. Furthermore, commercial melatonin products routinely supply doses that far exceed normal biological levels in the brain and body. This hormonal excess can disrupt other physiological systems without curing nighttime waking.
Andrew Huberman notes that while 100 to 400 milligrams of theanine helps many people fall asleep, it triggers excessively vivid dreams in others. These intense dreams can jolt individuals awake in the middle of the night with anxiety. For staying asleep, Huberman instead suggests testing 900 milligrams of myo-inositol.
Andrew Huberman highlights that taking 600 milligrams of Fadogia agrestis daily can elevate testosterone, libido, and sperm production. However, high doses carry documented toxicity to testicular cells. Huberman recommends cycling the herb—either eight weeks on followed by two weeks off, or twelve weeks on with a full month off.
Andrew Huberman observes that shifting hormone levels across the follicular and luteal phases alter how female physiology responds to supplementation. A compound can produce entirely different, or even opposite, biological effects depending on the cycle phase. Consequently, women require single-ingredient formulations and precise dosing control rather than blended multi-ingredient products.
Andrew Huberman identifies high-quality omega-3 fish oil providing over one gram of EPA daily as the single most impactful individual supplement. This threshold supports cardiovascular health, metabolic function, mood stabilization, and focused cognitive work. Many retail bottles advertise high total fish oil while falling below the therapeutic one-gram EPA benchmark.
Andrew Huberman distinguishes alertness compounds like caffeine and alpha-yohimbine from focus-tightening neuromodulators such as alpha-GPC and L-tyrosine. While stimulants broadly raise arousal and sympathetic tone, choline donors specifically sharpen mental focus without inducing jitters. Testing these agents independently clarifies which biological mechanism supports a specific cognitive work bout.
